Immunosuppressive agents such as corticosteroids, calcineurin inhibitors, and mTOR inhibitors are known to contribute to post-transplant hypertension, dyslipidemia, glucose intolerance, and central adiposity [9,10,11,12,13,14,15,16,17,18]. The gene discussed is MTOR; the disease is metabolic syndrome.